Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-21

Clinical Trial Update: Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ketone monitoring in type 1 diabetes and the effect of SGLT2 inhibitors during usual care and under insulin-deficient c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SGLT2 inhibitor

Snippet

Sponsor: Washington University School of Medicine | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED | Results posted: 2025-02-21